Ascendia Pharmaceutical Solutions provides state-of-the-art formulation development services for poorly water soluble molecules, and cGMP manufacture of clinical trial materials.  Applying its nano-particle technologies and expertise, Ascendia can rapidly assess the feasibility of a broad array of formulation options in order to improve a drug’s bioavailability.  Our technologies include nano-emulsions, amorphous solid dispersions, oral controlled release, self-emulsifying drug delivery systems (SEDDs) and production of nano-particles.  Ascendia provides development and testing services – from pre-formulation through to manufacture of pilot clinical supplies.

We execute rapid, comprehensive, and cost-effective programs for our clients.  We partner with emerging, discovery-stage pharmaceutical companies to provide early-stage formulations; with generic companies that seek enabling technology for ANDA development projects; and with specialty pharmaceutical companies that need development of new 505(b)(2) products for clinical testing.

Ascendia’s headquarters, laboratories and manufacturing suites are located in central New Jersey.  Ascendia is a privately-held company with a mission to provide customized formulation solutions to salvage difficult compounds and to create advanced medicines to help patients prevail over their disease and enhance their quality of life.